SS Innovations International

[PRIVATE]

Service & Cobot Robotics · HQ: United States, · Est. by Dr. Sudhir Srivastava, a globally acclaimed robotic cardiac surgeon, the company aims to make robotic surgery more affordable and accessible globally. The SSi Mantra 3 system covers general, urological, colorectal, gynecological, and cardiac surgical indications, and the company submitted its FDA 510(k) filing in late 2025. · 1 model registered · 6 deployments

New deployment

As of Sep 2026, DEPLOY verifies SS Innovations International: 1 model, 6 deployments across 2 regions, $25.8M raised. 2 sources back the record.

Ownership

PRIVATE

Capital / Funding

$26M

Headquarters

United States,

IP / Patents

Undisclosed

Platform Models

1

Audited Incidents

0

Overview

US-based medical technology company (Nasdaq: SSII) developing the SSi Mantra multi-specialty surgical robotic system. Founded by Dr. Sudhir Srivastava, a globally acclaimed robotic cardiac surgeon, the company aims to make robotic surgery more affordable and accessible globally. The SSi Mantra 3 system covers general, urological, colorectal, gynecological, and cardiac surgical indications, and the company submitted its FDA 510(k) filing in late 2025.

Audited Posture AssessmentPeer Percentile: 81.1%

Clean safety record across 6 verified deployments. Strong deployment footprint with 6 operational sites across 6 countries. Thin IP estate relative to category peers.

  • PUBLIC
  • SURGICAL

Key Facts

TickerNasdaq: SSII
Systems installed138 across 8 countries
Procedures performed7,300+
FDA status510(k) submitted late 2025
CEODr. Sudhir Srivastava
StockNasdaq: SSII
ProductSSi Mantra 3 surgical robotic system
Funding raised8.6M (2025)

Safety & Regulatory Posture

1 entry
Audited Incident & Recall Footprint

No incidents on record for SS Innovations International.

Evidentiary Regulatory Filings & Recalls

  • us_fda[pending]us_fda
    Dec 8, 2025

Leadership & Founders

2 entries

Current Program Leadership & Executives

Sudhir Srivastavareported, not verified

Founder, Chairman & CEO

Founding Team

Sudhir Srivastava[Founder]

cofounder

Partnerships & Commercial Deployments

2 entries
Total Tracked0
Operating0
Announced0
Concluded0

Operator Customers & Fleet Integrators

SS Innovations International - 6 deploymentsSS Innovations International

Platform Models

1 entry

Deployments

6 entries

Sectors & Applications

1 entry

FAQ

13 entries
What is SS Innovations International?

US-based medical technology company (Nasdaq: SSII) developing the SSi Mantra multi-specialty surgical robotic system. Founded by Dr. Sudhir Srivastava, a globally acclaimed robotic cardiac surgeon, the company aims to make robotic surgery more affordable and accessible globally. The SSi Mantra 3 system covers general, urological, colorectal, gynecological, and cardiac surgical indications, and the company submitted its FDA 510(k) filing in late 2025.

What does SS Innovations International make?

SS Innovations International has 1 robot model on the DEPLOY registry: SSi Mantra (SS Innovations International builds physical robots).

Is SS Innovations International publicly traded?

No. SS Innovations International is privately held and not publicly traded, per the DEPLOY registry.

Who competes with SS Innovations International?

On the DEPLOY registry, peer companies to SS Innovations International building in the same form factors include Brainlab, EndoQuest Robotics, Intuitive Surgical, LEM Surgical.

Who is the CEO of SS Innovations International?

Sudhir Srivastava is the ceo of SS Innovations International, per the DEPLOY registry.

How can I invest in SS Innovations International?

SS Innovations International is a private company; its shares are not available on public markets, so retail investors cannot buy the stock today. It has raised $26M in disclosed funding.

Where is SS Innovations International headquartered?

SS Innovations International is headquartered in United States.

How much funding has SS Innovations International raised?

SS Innovations International has raised approximately $26M in disclosed funding on record in the DEPLOY registry.

Who owns SS Innovations International?

SS Innovations International is privately held and venture-backed ($26M raised); ownership sits with its founders and private investors.

Where does SS Innovations International operate robots?

SS Innovations International operates 6 verified deployments, including at India, Continental Hospital, Apex Hospital.

How many robots has SS Innovations International deployed?

DEPLOY has 6 verified SS Innovations International deployments on record at sites including India, Continental Hospital, Apex Hospital. That is a count of distinct field deployments each backed by sourced evidence, not a manufacturer's claimed unit total; it updates as new sites are verified.

Is SS Innovations International a top robotics company?

On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, SS Innovations International ranks in roughly the top 19% of companies tracked by the registry.

Is SS Innovations International safe?

SS Innovations International has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.